Candela Frax Pro (Nordlys)
Non-Ablative Fractional · 1550nm + 1940nm fractional
Technology: IPL
Classification & configurations
Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)
Current
At a glance
- New price
- Not published
- FDA status
- Supplies & recurring costs
- Supply details not yet documented.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers.
Read FDA-cleared indicationsExact wording from 3 FDA records
K161162 (Ellipse A/S, 2016)
Ellipse Nordlys system is intended to be used in dermatology, as tabled below: • Permanent Hair Reduction (defined as the long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime) (overall 600-950nm). • Treatment of Telangiectasias (530-750nm or 555-950nm). • Treatment of Port Wine Stains (530-750nm or 555-950nm). • Treatment of Benign Pigmented Lesions (eg Mottled Pigmentation, Ephilides) and Benign Vascular Lesions (eg Diffuse Redness) (530-750nm or 555-950nm). • Treatment of Rosacea (530-750nm or 555-950nm). • Treatment of Poikiloderma of Civatte (530-750nm or 555-950nm). • Treatment of Benign Epidermal Pigmented Lesions (eg Lentigo Solaris) (400-720nm). • Treatment of Inflammatory Acne Vulgaris (530-750nm). Using Nd:YAG Laser, (1064 nm): • Treatment of Leg vessels (0.1 -3.0 mm diameter). • Treatment of Benign Vascular Lesions. • Treatment of Venous Lakes. • Treatment of Port Wine Stains. • Treatment for Clear Nail defined as: Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.). • Treatment of benign cutaneous lesions, such as warts. • Podiatry (ablation, vaporization, incision, excision, and coagulation of soft tissue), including: - Matrixectomy. - Periungal and subungal warts - Plantar warts. Using Frax 1550 Laser, (1550 nm): • The Frax 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K192951 (Ellipse A/S, 2020)
Ellipse Nordlys system is intended to be used in dermatology, as tabled below: * Permanent Hair Reduction (defined as teh long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime)(overall 600 - 950 nm). * Treatment of Telangiectasias (530-750 nm or 555-950 nm) * Treatment of Port Wine Stains (530-750 nm or 555-950 nm) * Treatment of Benign Pigmented Lesions (eg Mottled Pigmentation, Ephilides) and Benign Vascular Lesions (eg Diffuse Redness) (530-750 nm or 555-950 nm) * Treatment of Rosacea (530-750 nm or 555-950 nm) * Treatment of Poikiloderma of Civatte (530-750 nm or 555-950 nm) * Treatment of Benign Epidermal Pigmented Lesions (eg Lentigo Solaris)(400-720 nm) * Treatment of Inflammatory Acne Vulgaris (530-750 nm) Ellipse Nordlys + Nd:YAG Laser (1064 nm): *Treatment of Leg Vessels (0.1-3.0 mm diameter). * Treatment of Benign Vascular Lesions. * Treatment of Venous Lakes. * Treatment of Port Wine Stains. * Treatment for Clear Nail defined as: Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.). * Treatment of benign cutaneous lesions, such as warts. Podiatry (ablation, vaporization, incision, and coagulation of soft tissue), including: - Matrixectomy - Periungal and subungal warts - Plantar warts. Ellipse Nordlys + Frax 1550 Laser, (1550 nm) * The Frax 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. Ellipse Nordlys + Frax 1940 Laser (1940 nm): * The Frax 1940 nm Laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue and general skin resurfacing procedures. Ellipse Ydun system is intended to be used in dermatology, as tabled below: Ellipse Ydun + Frax 1550, (1550 nm): *The Frax 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K212492 (Candela Corporation, 2021)
Nordlys system is intended to be used in dermatology as listed below: Nordlys System + Intense pulse light applicators: • Permanent Hair Reduction (defined as the long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regimen) (overall 600 - 950 nm) • Treatment of Telangiectasias (530-750 nm or 555-950 nm) • Treatment of Port Wine Stains (530-750 nm or 555-950 nm) • Treatment of Benign Pigmented Lesions (eg Mottled Pigmentation, Ephelides) and Benign Vascular Lesions (eg Diffuse Redness) (530-750 nm or 555-950 nm) • Treatment of Rosacea (530-750 nm or 555-950 nm) • Treatment of Poikiloderma of Civatte (530-750 nm or 555-950 nm) • Treatment of Benign Epidermal Pigmented Lesions (eg Solar Lentigines) (400-720 nm) • Treatment of Inflammatory Acne Vulgaris (530-750 nm). Nordlys System + Nd:YAG Laser (1064 nm): • Treatment of Leg Vessels (0.1-3.0 mm diameter) • Treatment of Benign Vascular Lesions • Treatment of Venous Lakes • Treatment of Port Wine Stains • Treatment for Clear Nail defined as: Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.) • Treatment of benign cutaneous lesions, such as warts • Podiatry (ablation, vaporization, incision, and coagulation of soft tissue), including: Matrixectomy; Periungal and subungal warts; Plantar warts. Nordlys System + Frax 1940 Laser (1940 nm): • The Frax 1940 is indicated for use in dermatological procedures requiring the coagulation of soft tissue and for skin resurfacing procedures.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: August 6, 2026 · How we verify
No new-equipment price range is published for this model. Ask the seller for a dated, itemized quote covering configuration, training and service.
Price sourcesSources, dates and configurations
No price sources are documented yet. Ask the seller for a current, itemized quote.
Key factsCompany, specifications and verification dates
| Manufacturer | Candela |
|---|---|
| Company | Owner: Apax Partners (funds advised by Apax) (private equity owned, since 2017) · Distribution: direct |
| Parent company | Candela Medical |
| Brand owner | Candela |
| Built by (OEM) | Candela Corporation |
| Category | Non-Ablative Fractional |
| Technology | 1550nm + 1940nm fractional |
| FDA status | FDA Cleared |
| 510(k) citation | K161162, K192951, K212492 |
| New price range | Not published |
| Used asking range | Not published |
| Consumables | Not published |
| Launch year | 2022 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Dual-depth fractional on Nordlys platform
FDA & regulatory detailClearance timeline, authorization route and citation notes
FDA ClearedAuthorized via 510(k)
FDA-cleared indications (verbatim)
K161162 (Ellipse A/S, 2016)
Ellipse Nordlys system is intended to be used in dermatology, as tabled below: • Permanent Hair Reduction (defined as the long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime) (overall 600-950nm). • Treatment of Telangiectasias (530-750nm or 555-950nm). • Treatment of Port Wine Stains (530-750nm or 555-950nm). • Treatment of Benign Pigmented Lesions (eg Mottled Pigmentation, Ephilides) and Benign Vascular Lesions (eg Diffuse Redness) (530-750nm or 555-950nm). • Treatment of Rosacea (530-750nm or 555-950nm). • Treatment of Poikiloderma of Civatte (530-750nm or 555-950nm). • Treatment of Benign Epidermal Pigmented Lesions (eg Lentigo Solaris) (400-720nm). • Treatment of Inflammatory Acne Vulgaris (530-750nm). Using Nd:YAG Laser, (1064 nm): • Treatment of Leg vessels (0.1 -3.0 mm diameter). • Treatment of Benign Vascular Lesions. • Treatment of Venous Lakes. • Treatment of Port Wine Stains. • Treatment for Clear Nail defined as: Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.). • Treatment of benign cutaneous lesions, such as warts. • Podiatry (ablation, vaporization, incision, excision, and coagulation of soft tissue), including: - Matrixectomy. - Periungal and subungal warts - Plantar warts. Using Frax 1550 Laser, (1550 nm): • The Frax 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K192951 (Ellipse A/S, 2020)
Ellipse Nordlys system is intended to be used in dermatology, as tabled below: * Permanent Hair Reduction (defined as teh long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regime)(overall 600 - 950 nm). * Treatment of Telangiectasias (530-750 nm or 555-950 nm) * Treatment of Port Wine Stains (530-750 nm or 555-950 nm) * Treatment of Benign Pigmented Lesions (eg Mottled Pigmentation, Ephilides) and Benign Vascular Lesions (eg Diffuse Redness) (530-750 nm or 555-950 nm) * Treatment of Rosacea (530-750 nm or 555-950 nm) * Treatment of Poikiloderma of Civatte (530-750 nm or 555-950 nm) * Treatment of Benign Epidermal Pigmented Lesions (eg Lentigo Solaris)(400-720 nm) * Treatment of Inflammatory Acne Vulgaris (530-750 nm) Ellipse Nordlys + Nd:YAG Laser (1064 nm): *Treatment of Leg Vessels (0.1-3.0 mm diameter). * Treatment of Benign Vascular Lesions. * Treatment of Venous Lakes. * Treatment of Port Wine Stains. * Treatment for Clear Nail defined as: Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.). * Treatment of benign cutaneous lesions, such as warts. Podiatry (ablation, vaporization, incision, and coagulation of soft tissue), including: - Matrixectomy - Periungal and subungal warts - Plantar warts. Ellipse Nordlys + Frax 1550 Laser, (1550 nm) * The Frax 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. Ellipse Nordlys + Frax 1940 Laser (1940 nm): * The Frax 1940 nm Laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue and general skin resurfacing procedures. Ellipse Ydun system is intended to be used in dermatology, as tabled below: Ellipse Ydun + Frax 1550, (1550 nm): *The Frax 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K212492 (Candela Corporation, 2021)
Nordlys system is intended to be used in dermatology as listed below: Nordlys System + Intense pulse light applicators: • Permanent Hair Reduction (defined as the long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of a treatment regimen) (overall 600 - 950 nm) • Treatment of Telangiectasias (530-750 nm or 555-950 nm) • Treatment of Port Wine Stains (530-750 nm or 555-950 nm) • Treatment of Benign Pigmented Lesions (eg Mottled Pigmentation, Ephelides) and Benign Vascular Lesions (eg Diffuse Redness) (530-750 nm or 555-950 nm) • Treatment of Rosacea (530-750 nm or 555-950 nm) • Treatment of Poikiloderma of Civatte (530-750 nm or 555-950 nm) • Treatment of Benign Epidermal Pigmented Lesions (eg Solar Lentigines) (400-720 nm) • Treatment of Inflammatory Acne Vulgaris (530-750 nm). Nordlys System + Nd:YAG Laser (1064 nm): • Treatment of Leg Vessels (0.1-3.0 mm diameter) • Treatment of Benign Vascular Lesions • Treatment of Venous Lakes • Treatment of Port Wine Stains • Treatment for Clear Nail defined as: Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.) • Treatment of benign cutaneous lesions, such as warts • Podiatry (ablation, vaporization, incision, and coagulation of soft tissue), including: Matrixectomy; Periungal and subungal warts; Plantar warts. Nordlys System + Frax 1940 Laser (1940 nm): • The Frax 1940 is indicated for use in dermatological procedures requiring the coagulation of soft tissue and for skin resurfacing procedures.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
IPL — 1550nm + 1940nm fractional
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Candela Medical
Legal manufacturer: Candela Corporation (United States)
Applicant on the FDA record
Ellipse A/SThe applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Consumable costs are not documented yet.
Annual service & support
No annual service cost documented yet.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History5 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA indication
Source: Catalog update
August 5, 2026
FDA K-numbers
Source: Catalog update
August 5, 2026
FDA status
Unknown → Cleared
Source: Catalog update
August 5, 2026
FDA indication
1550/1940nm non-ablative fractional resurfacing
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Candela Frax Pro (Nordlys) — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.